Transnasal Thermal Regulating Device
DevicePlacement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours
NCT Number: NCT03360656
The objective of this study is to evaluate safety and performance of the COOLSTAT® Transnasal Thermal Regulating Device in reducing temperature in a population of febrile subjects who meet the inclusion/exclusion criteria.
Looking for future studies?
Notify Me18 year–95 year
All sexes
Interventional
Not applicable
MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Placement of transnasal thermal regulating device to reduce temperature in febrile patients for a period of 8 to 24 hours
Time frame: 4 hours
Ability of transnasal thermal regulating device to reduce core body temperature within 4 hours of initiation
CoolTech LLC
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04000971
Behavior, Brain Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT04038697
Brain Diseases, Cardiovascular Diseases
Milwaukee, Wisconsin, United States
View Trial DetailsNCT05936008
Behavior, Brain Diseases
Kansas City, Kansas, United States
View Trial DetailsNCT05029284
Brain Diseases, Cardiovascular Diseases
Minneapolis, Minnesota, United States
View Trial Details